Core Viewpoint - SelectQuote's share price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage market [1][3]. Group 1: Lawsuit and Allegations - The U.S. Department of Justice filed a lawsuit against SelectQuote and other insurance brokers, claiming they violated the False Claims Act [1]. - The investigation focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. - Allegations include that SelectQuote directed Medicare beneficiaries to plans that provided the highest kickbacks to brokers, rather than acting in the best interest of the beneficiaries [5]. Group 2: Financial Impact - Following the announcement of the lawsuit, SelectQuote's shares fell by over 19% on May 1, 2025 [1][3]. - The lawsuit raises concerns about the potential inflation of SelectQuote's financial results due to alleged steering practices [4]. Group 3: Whistleblower Information - Whistleblowers with non-public information regarding SelectQuote are encouraged to assist in the investigation, with potential rewards of up to 30% of any successful recovery made by the SEC [4].

Core Viewpoint - Kirby McInerney LLP is investigating potential claims against GoHealth, Inc. regarding possible violations of federal securities laws and unlawful business practices [1] Group 1: Legal Investigation - The investigation focuses on whether GoHealth and/or its officers have engaged in unlawful business practices [1] - The U.S. Department of Justice filed a complaint against GoHealth, alleging that the company received illegal kickbacks from insurers for enrollments in Medicare Advantage plans [3] Group 2: Financial Impact - Following the DOJ complaint, GoHealth's share price dropped by $1.09, from $10.53 on April 30, 2025, to $9.44 on May 1, 2025 [3]

NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On May 1, 2025, the U ...

NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. ("GoHealth" or the "Company") (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2025, the U.S. De ...

Core Viewpoint - The U.S. Department of Justice has filed a False Claims Act complaint against SelectQuote and other health insurance companies, alleging illegal kickbacks related to Medicare Advantage plans, leading to a significant drop in SelectQuote's stock price [2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against SelectQuote on behalf of its stockholders for possible violations of federal securities laws and unlawful business practices [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ lawsuit, SelectQuote's stock price decreased by $0.61 per share, representing a 19.24% decline, closing at $2.56 per share on May 1, 2025 [2].

Group 1 - Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1] - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth and other health insurance companies, alleging that from 2016 to at least 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [3] - Following the DOJ's lawsuit announcement, GoHealth's stock price dropped by $1.09 per share, a decrease of 10.35%, closing at $9.44 per share on May 1, 2025 [3]

Company Overview - SelectQuote, Inc. is an insurance broker that specializes in selling Medicare Advantage and other health insurance plans [3]. Legal Investigation - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving SelectQuote, focusing on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1]. - The U.S. Department of Justice filed a complaint against SelectQuote and other insurance broker organizations, alleging that they received illegal kickbacks from insurers in exchange for enrollments into Medicare Advantage plans [3]. Market Impact - Following the announcement of the DOJ complaint, SelectQuote's stock price experienced a significant decline, falling more than 19% [3].

Financial Data and Key Metrics Changes - The company reported a 14% growth in revenue for the combined brokerage and risk management segments, with 9% organic growth and a net earnings margin of 23% [4][5] - Adjusted EBITDAC margin increased to 41.1%, up 338 basis points year over year, with adjusted EBITDAC growth of 26% [4][5] - GAAP earnings per share were $3.29, while adjusted earnings per share were $4.16 [5] Segment Performance Changes - The Brokerage segment saw reported revenue growth of 16% and organic growth of 9.5%, with adjusted EBITDAC margin expanding to 43.4% [5][6] - Retail PC operations delivered 5% organic growth, with U.S. operations exceeding 5% and international operations around 4% [6][7] - The Reinsurance, Wholesale, and Specialty businesses achieved a total organic growth of 13%, with Gallagher Reed contributing 20% organic growth [7] Market Data and Key Metrics Changes - In the primary insurance market, overall global property renewal premiums decreased by 2%, while D&O premiums fell by 3%. Workers' compensation premiums increased by 5%, and personal lines and casualty lines rose by 8% [8][9] - For small to mid-sized accounts, renewal premiums were up 5%, while large accounts saw a 1% increase [9][10] Company Strategy and Industry Competition - The company aims to leverage its expertise in navigating the complex insurance market to provide optimal coverage for clients while mitigating price increases [11] - The reinsurance market dynamics favored buyers, with reinsurers maintaining discipline on terms while meeting increased client demand [11][12] - The company is well-positioned to compete and win, emphasizing its niche expertise and extensive data analytics capabilities [16] Management's Comments on Operating Environment and Future Outlook - Management noted solid client business activity with no signs of a meaningful global economic slowdown, despite some upward revenue adjustments being lower than the previous year [14][16] - The U.S. labor market remains strong, with over 7 million open jobs, indicating a robust demand for new workers [15][16] - The company expects full-year 2025 brokerage segment organic growth in the range of 6% to 8% [17] Other Important Information - The company completed 11 tuck-in mergers during the first quarter, representing approximately $100 million of estimated annualized revenue [19] - The acquisition of Woodruff Sawyer was completed in early April, contributing to a total of $400 million of acquired revenue [19] - The company has over 40 term sheets signed or being prepared, representing more than $450 million of annualized revenue [20] Q&A Session Summary Question: Breakdown of 20% growth in reinsurance - Management indicated that over half of the organic growth came from new business, with significant client wins and increased renewal premiums contributing to the growth [42][44] Question: Update on Assured Partners acquisition - Management is preparing a response to the DOJ and expects to submit it by mid-third quarter, starting a 30-day review period [47][49] Question: Impact of timing on organic growth - Management clarified that the timing impact was primarily in reinsurance, with expectations of a similar effect in the second quarter, but no overall impact on full-year organic growth [50][54] Question: Renewal pricing bifurcation - Management confirmed that larger accounts are experiencing less rate pressure compared to smaller accounts, which are seeing higher increases [56][58] Question: Organic profile at Assured Partners - Management expressed confidence that the organic profile at Assured Partners is similar to their retail business, with strong retention rates [64][68]

Arthur J. Gallagher (AJG) Q1 2025 Earnings Call May 01, 2025 05:30 PM ET Company Participants Patrick Gallagher, Jr - CEO & Chairman of The BoardDouglas K. Howell - CFOElyse Greenspan - Managing DirectorC. Gregory Peters - Managing Director - InsuranceKatie Sakys - US P&C Insurance, Senior AssociateAndrew Andersen - Equity Research Vice PresidentMeyer Shields - Managing Director Conference Call Participants Michael Zaremski - Managing Director & Senior Equity Research AnalystMark Hughes - AnalystDavid Monte ...

First Quarter 2025 Results April 28, 2025 Information Regarding Non-GAAP Measures This presentation contains references to "non-GAAP financial measures" as defined in SEC Regulation G, consisting of Organic Revenue, EBITDAC, EBITDAC Margin, EBITDAC - Adjusted, EBITDAC Margin - Adjusted, Income Before Income Taxes - Adjusted, Income Before Income Taxes Margin - Adjusted, Net Income Attributable To The Company - Adjusted and Diluted Net Income Per Share - Adjusted. We present these measures because we believe ...